Fairfield Bush & CO. decreased its position in Amgen Inc. ( NASDAQ:AMGN – Get Rating ) by 20.6% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,881 shares of the medical research company's stock after selling 489 shares during the quarter. Fairfield Bush & CO.'s holdings in Amgen were worth $494,000 as of its most recent filing with the Securities and Exchange Commission (SEC). A number of other large investors have also added to or reduced their stakes in AMGN.
https://www.dailypolitical.com/2023/06/14/fairfield-bush-co-sells-489-shares-of-amgen-inc-nasdaqamgn.html#dailypolitical
Sinun täytyy kirjautua sisään ennen kuin voit kommentoida.